Pub. Date : 1999 Apr 12
PMID : 10188728
6 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Treatment with low (nanomolar) concentrations of phorbol-12-myristate-13-acetate (PMA) for 5 to 30 min suppresses locomotion of Walker 256 carcinosarcoma cells, suggesting that activation of protein kinase C (PKC) is a stop signal for tumor cell locomotion. | Tetradecanoylphorbol Acetate | protein kinase C, alpha | Rattus norvegicus |
2 | Treatment with low (nanomolar) concentrations of phorbol-12-myristate-13-acetate (PMA) for 5 to 30 min suppresses locomotion of Walker 256 carcinosarcoma cells, suggesting that activation of protein kinase C (PKC) is a stop signal for tumor cell locomotion. | Tetradecanoylphorbol Acetate | protein kinase C, alpha | Rattus norvegicus |
3 | Long-term incubation with PMA (0.1 microM, 6 hr) resulted in significant reduction of expression of conventional PKCs alpha, betaI, betaII and gamma and of the novel PKC eta to 10% to 26% of controls. | Tetradecanoylphorbol Acetate | protein kinase C, alpha | Rattus norvegicus |
4 | Long-term incubation with PMA (0.1 microM, 6 hr) resulted in significant reduction of expression of conventional PKCs alpha, betaI, betaII and gamma and of the novel PKC eta to 10% to 26% of controls. | Tetradecanoylphorbol Acetate | protein kinase C, alpha | Rattus norvegicus |
5 | Motility and polarized shape of the down-regulated cells were no longer susceptible to short-term treatment with PMA, showing that active PKC is indeed responsible for the inhibitory effects of PMA. | Tetradecanoylphorbol Acetate | protein kinase C, alpha | Rattus norvegicus |
6 | Motility and polarized shape of the down-regulated cells were no longer susceptible to short-term treatment with PMA, showing that active PKC is indeed responsible for the inhibitory effects of PMA. | Tetradecanoylphorbol Acetate | protein kinase C, alpha | Rattus norvegicus |